Trial Profile
Efficacy of switching of azilsartan from candesartan in renal patients with hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Azilsartan (Primary) ; Candesartan cilexetil
- Indications Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 28 Dec 2015 New trial record